V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240004893 | 240003332 | null | 79 | null | null | 2017-07-01 | BENDAMUSTINE + RITUXIMAB | N | N | 240025865 | BENDAMUSTINE + RITUXIMAB |
| 240004894 | 240003333 | 1.72 | 93 | Palliative (P) | 2013-11-28 | 2013-11-29 | Rituximab | 2 | N | 240025866 | RITUXIMAB |
| 240004895 | 240003334 | 1.6 | 62.9 | null | 2014-05-13 | 2014-07-14 | Rituximab | null | N | 240025869 | RITUXIMAB |
| 240004896 | 240003335 | 1.69 | 115 | Curative (C) | 2015-08-19 | 2016-02-06 | Bendamustine+Rituximab (1st Course) | N | N | 240025870 | BENDAMUSTINE + RITUXIMAB |
| 240004897 | 240003336 | 1.64 | null | Disease modification (D) | 2015-07-07 | 2015-08-11 | Rituximab | N | N | 240025871 | RITUXIMAB |
| 240004898 | 240003336 | 1.74 | 87 | Palliative (P) | 2014-03-03 | 2014-03-03 | Rituximab | 02 | null | 240025871 | RITUXIMAB |
| 240004899 | 240003337 | 1.73 | null | Palliative (P) | 2015-02-19 | 2015-03-08 | Rituximab | N | null | 240025876 | RITUXIMAB |
| 240004900 | 240003338 | null | 100 | Palliative (P) | 2016-12-28 | 2017-02-01 | Bendamustine+Rituximab (1st Course) | N | N | 240025879 | BENDAMUSTINE + RITUXIMAB |
| 240004901 | 240003338 | 1.81 | 56.9 | Palliative (P) | 2014-04-25 | 2014-05-21 | Rituximab | N | N | 240025879 | RITUXIMAB |
| 240004902 | 240003339 | null | 85 | Disease modification (D) | 2014-07-08 | 2014-07-10 | Bendamustine+Rituximab(Sub Courses) | N | N | 240025892 | BENDAMUSTINE + RITUXIMAB |
| 240004904 | 240003341 | null | 55.6 | Disease modification (D) | 2018-03-07 | 2018-03-15 | BENDAMUSTINE + RITUXIMAB | N | N | 240025899 | BENDAMUSTINE + RITUXIMAB |
| 240004905 | 240003342 | 1.57 | 68 | null | null | 2017-09-23 | BENDAMUSTINE + RITUXIMAB | N | N | 240025900 | BENDAMUSTINE + RITUXIMAB |
| 240004906 | 240003343 | 1.85 | 75 | Curative (C) | 2013-08-16 | 2013-08-21 | Rituximab | 02 | N | 240025901 | RITUXIMAB |
| 240004907 | 240003344 | 1.64 | 122 | Palliative (P) | 2017-06-10 | 2017-06-29 | BENDAMUSTINE + RITUXIMAB | 2 | N | 240025903 | BENDAMUSTINE + RITUXIMAB |
| 240004908 | 240003345 | 1.55 | 63.5 | Palliative (P) | 2016-07-13 | 2016-07-14 | Rituximab | 2 | N | 240025904 | RITUXIMAB |
| 240004909 | 240003345 | 1.75 | 186 | Not known (9) | null | 2014-10-19 | Rituximab | N | null | 240025904 | RITUXIMAB |
| 240004910 | 240003346 | 1.63 | 87.45 | Palliative (P) | 2018-04-24 | 2018-04-30 | BENDAMUSTINE + RITUXIMAB | 02 | N | 240025908 | BENDAMUSTINE + RITUXIMAB |
| 240004911 | 240003346 | 1.59 | 57 | Palliative (P) | 2018-03-13 | 2018-03-15 | Rituximab | N | N | 240025908 | RITUXIMAB |
| 240004912 | 240003347 | 1.69 | 69 | Disease modification (D) | 2013-12-27 | 2014-01-12 | Rituximab | N | null | 240025910 | RITUXIMAB |
| 240004913 | 240003347 | null | 65.5 | Curative (C) | 2014-11-14 | 2014-11-29 | Bendamustine+Rituximab (1st Course) | N | N | 240025910 | BENDAMUSTINE + RITUXIMAB |
| 240004914 | 240003348 | 1.49 | 52.3 | Palliative (P) | null | 2017-07-04 | Rituximab | N | N | 240025913 | RITUXIMAB |
| 240004915 | 240003349 | null | null | Curative (C) | null | 2018-08-03 | BENDAMUSTINE + RITUXIMAB | Y | null | 240025914 | BENDAMUSTINE + RITUXIMAB |
| 240004916 | 240003349 | null | 63.3 | Curative (C) | 2017-07-07 | 2017-07-09 | Bendamustine+Rituximab (1st Course) | N | N | 240025914 | BENDAMUSTINE + RITUXIMAB |
| 240004917 | 240003349 | 1.55 | 63.3 | Palliative (P) | 2017-10-01 | 2017-10-01 | Bendamustine+Rituximab (1st Course) | 2 | N | 240025914 | BENDAMUSTINE + RITUXIMAB |
| 240004918 | 240003350 | 1.5 | 59.3 | Disease modification (D) | 2013-06-11 | 2013-06-23 | BENDAMUSTINE + RITUXIMAB | 02 | N | 240025917 | BENDAMUSTINE + RITUXIMAB |
| 240004919 | 240003351 | 1.66 | null | Disease modification (D) | 2016-06-01 | 2016-06-02 | Rituximab | 02 | N | 240025920 | RITUXIMAB |
| 240004920 | 240003351 | null | 84 | Curative (C) | 2015-04-02 | 2015-04-09 | Rituximab | 02 | null | 240025920 | RITUXIMAB |
| 240004921 | 240003352 | 1.66 | null | Disease modification (D) | 2014-07-22 | 2014-07-24 | Rituximab | 2 | N | 240025926 | RITUXIMAB |
| 240004922 | 240003353 | null | 67.4 | null | 2014-03-23 | 2014-03-26 | Rituximab | N | null | 240025928 | RITUXIMAB |
| 240004923 | 240003353 | null | 86 | null | 2014-02-11 | 2014-02-12 | Bendamustine+Rituximab (1st Course) | 2 | N | 240025928 | BENDAMUSTINE + RITUXIMAB |
| 240004924 | 240003354 | 1.62 | 54.199 | Not known (9) | 2016-09-10 | 2016-10-09 | Rituximab (Maintenance) | N | N | 240025932 | RITUXIMAB |
| 240004925 | 240003354 | 1.61 | 64 | Disease modification (D) | 2015-01-28 | 2015-02-04 | Rituximab | 2 | N | 240025932 | RITUXIMAB |
| 240004926 | 240003355 | 1.67 | 99 | Disease modification (D) | 2018-01-12 | 2018-01-12 | Rituximab | N | N | 240025940 | RITUXIMAB |
| 240004927 | 240003356 | null | 54 | Curative (C) | 2016-04-06 | 2016-04-06 | Bendamustine+Rituximab (1st Course) | 2 | N | 240025941 | BENDAMUSTINE + RITUXIMAB |
| 240004928 | 240003356 | 1.6 | 70 | Curative (C) | 2013-08-02 | 2013-08-08 | BENDAMUSTINE + RITUXIMAB | N | Y | 240025941 | BENDAMUSTINE + RITUXIMAB |
| 240004929 | 240003356 | null | 73 | Neo-adjuvant (N) | 2014-06-11 | 2014-06-23 | Rituximab | N | N | 240025941 | RITUXIMAB |
| 240004930 | 240003357 | 1.52 | 62.2 | Curative (C) | 2014-05-31 | 2014-06-02 | BENDAMUSTINE + RITUXIMAB | N | null | 240025951 | BENDAMUSTINE + RITUXIMAB |
| 240004931 | 240003358 | 1.77 | 74.599 | Disease modification (D) | 2016-12-21 | 2017-01-09 | Rituximab | N | Y | 240025952 | RITUXIMAB |
| 240004932 | 240009935 | null | 112 | Curative (C) | null | 2015-01-07 | Bendamustine+Rituximab(Sub Courses) | N | null | 240025953 | BENDAMUSTINE + RITUXIMAB |
| 240004933 | 240009935 | 1.41 | 86.8 | Palliative (P) | 2017-09-13 | 2017-09-13 | BENDAMUSTINE + RITUXIMAB | 02 | N | 240025953 | BENDAMUSTINE + RITUXIMAB |
| 240004934 | 240003359 | 1.8 | 76.6 | Disease modification (D) | 2015-07-06 | 2015-07-19 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 240025955 | BENDAMUSTINE + RITUXIMAB |
| 240004935 | 240009936 | 1.75 | 65.9 | Curative (C) | 2014-04-17 | 2014-05-03 | BENDAMUSTINE + RITUXIMAB | 02 | N | 240025956 | BENDAMUSTINE + RITUXIMAB |
| 240004936 | 240003360 | 1.59 | null | Disease modification (D) | 2015-03-19 | 2015-03-19 | Rituximab | 02 | N | 240025970 | RITUXIMAB |
| 240004937 | 240003361 | 1.66 | 103 | Curative (C) | 2015-08-25 | 2015-08-25 | Rituximab | 2 | N | 240025974 | RITUXIMAB |
| 240004938 | 240003362 | 163 | 63.2 | Palliative (P) | 2017-09-15 | 2017-09-18 | BENDAMUSTINE + RITUXIMAB | 2 | N | 240025976 | BENDAMUSTINE + RITUXIMAB |
| 240004939 | 240003362 | 1.54 | 71.5 | Disease modification (D) | 2013-06-04 | 2013-06-17 | Rituximab | N | N | 240025976 | RITUXIMAB |
| 240004940 | 240003362 | 1.6 | 57 | Curative (C) | 2018-10-31 | 2018-11-04 | Rituximab | N | N | 240025976 | RITUXIMAB |
| 240004941 | 240003362 | 1.68 | 86.4 | Palliative (P) | 2017-01-14 | 2017-01-15 | Rituximab | 02 | N | 240025976 | RITUXIMAB |
| 240004942 | 240003362 | 1.73 | 77 | Disease modification (D) | 2015-01-07 | 2015-01-07 | Rituximab | N | N | 240025976 | RITUXIMAB |
| 240004943 | 240003362 | 0 | 59.5 | Palliative (P) | 2017-09-12 | 2017-10-04 | Bendamustine+Rituximab(Sub Courses) | N | N | 240025976 | BENDAMUSTINE + RITUXIMAB |